Breaking News Headlines Today | Ground News

See every side of every news story

Investor's Business Daily image

News from Investor's Business Daily

Investor's Business Daily’s aggregated media bias check is Lean Right. This is a score we've assigned by combining the media bias ratings of a leanRight rating from Ad Fontes Media, a Right rating from Media Bias/Fact Check, a leanRight rating from from All Sides.

Investor's Business Daily’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Investor's Business Daily

Where is Investor's Business Daily located?Investor's Business Daily's Website Investor's Business Daily's Twitter Investor's Business Daily's Wikipedia

Media Bias Ratings

Average Bias Rating:

Lean Right

Lean Right

byAd Fontes Media

Lean Right

Right

byMedia Bias/Fact Check

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Investor's Business Daily News

Warren Buffett’s Berkshire Hathaway reveals $4B stake in Google parent, sells more Apple — REUTERS / ixx511

Berkshire Hathaway · United States

Warren Buffett’s Berkshire Hathaway reveals $4B stake in Google parent, sells more Apple

42% Right coverage: 24 sources

Berkshire Hathaway revealed a $4.3 billion stake in Google parent Alphabet and further reduced its stake in Apple , detailing its equity portfolio for the last time before Warren Buffett ends his 60-year run as chief executive officer.See the Story

Peter Thiel Exits Nvidia Stake Amid AI Market Volatility — Marco Bello/Getty Images via Getty Images

Peter Thiel Exits Nvidia Stake Amid AI Market Volatility

44% Right coverage: 9 sources

Biotech Duo Skyrockets On 'Sweeping Success' In Cancer Treatment

Cancer · Toronto

Biotech Duo Skyrockets On 'Sweeping Success' In Cancer Treatment

Coverage: 5 sources

Shares of Jazz Pharmaceuticals and Zymeworks catapulted Monday after the duo unveiled positive test results for a gastric cancer drug.See the Story

Breaking News Topics Related to Investor's Business Daily